Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with CellBridge Incorporated
MINNEAPOLIS, March 21, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), formerly Skyline Medical, announced today that its ...
